Becton, Dickinson and Company Competitors & Alternatives
Becton, Dickinson and Company competitors and alternatives include Intuitive Surgical, etc.…
Jump
-
Stock Price
-
Market Cap
-
Employees
-
Income Statement
-
Revenue
-
Revenue by Product / Services
-
Revenue by Geography
-
Research and Development
-
Operating Income
-
Tax Rate (%)
-
Net Income
-
Assets & Liabilities | Cash Flow
-
Total Assets
-
Total Liabilities
-
Capital Expenditures (Capex)
-
Profitability
-
Operating Income Margin (%)
-
Net Income Margin (%)
-
EBITDA
-
Free Cash Flow (FCF)
-
Ratios
-
Return on Equity (ROE)
-
Return on Assets (ROA)
-
Debt to Equity
-
Valuation
-
Enterprise value
-
Enterprise value to Revenue
-
Enterprise value to EBITDA
Ticker
BDX
ISRG
Headquarter
Franklin Lakes
,NJ
US
Sunnyvale
,CA
US
CEO

Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
Stock Price
Stock Price
Market Cap
Market Cap
$54.91 B
$168.48 B
Employees
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Employees
- 77.00 K
- 73.00 K
- 74.00 K
- 12.12 K
- 13.68 K
- 15.64 K
Y/Y
2.67%
5.19%
1.37%
23.76%
12.84%
14.35%
Income Statement
Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Revenue
- $18.87 B
- $19.37 B
- $20.18 B
- $6.22 B
- $7.12 B
- $8.35 B
Y/Y
1.36%
2.66%
4.16%
8.97%
14.49%
17.24%
Revenue by Products / Services
Revenue by Geography
Research and Development
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Research and Development
- $1.26 B
- $1.24 B
- $1.19 B
- $879.00 M
- $998.80 M
- $1.15 B
Y/Y
1.8%
1.51%
3.8%
31%
13.63%
14.67%
Operating Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income
- $2.28 B
- $2.11 B
- $2.40 B
- $1.58 B
- $1.77 B
- $2.35 B
Y/Y
1.42%
7.49%
13.55%
13.39%
12.03%
32.95%
Tax Rate (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Tax Rate (%)
- 8.00%
- 8.00%
- 15.00%
- 16.00%
- 7.00%
- 13.00%
Y/Y
59.62%
4.34%
88.41%
90.33%
55.73%
74%
Net Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income
- $1.78 B
- $1.48 B
- $1.71 B
- $1.32 B
- $1.80 B
- $2.32 B
Y/Y
14.96%
16.58%
14.89%
22.43%
35.98%
29.18%
Revenue Per Employee
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Revenue Per Employee
- $245.06 K
- $265.37 K
- $272.68 K
- $513.38 K
- $520.92 K
- $534.09 K
Y/Y
3.93%
8.29%
2.75%
11.95%
1.47%
2.53%
Net Income Per Employee
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income Per Employee
- $23.10 K
- $20.33 K
- $23.04 K
- $109.10 K
- $131.47 K
- $148.52 K
Y/Y
17.17%
12.01%
13.34%
37.32%
20.5%
12.97%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Assets
- $52.93 B
- $52.78 B
- $57.29 B
- $12.97 B
- $15.44 B
- $18.84 B
Y/Y
1.76%
0.29%
8.54%
4.29%
19.02%
22%
Total Liabilities
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Liabilities
- $27.65 B
- $26.98 B
- $31.40 B
- $1.86 B
- $2.04 B
- $2.31 B
Y/Y
8.45%
2.42%
16.36%
16.08%
9.82%
12.95%
Capital Expenditures (Capex)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Capital Expenditures (Capex)
- -$973.00 M
- -$874.00 M
- -$725.00 M
- -$532.40 M
- -$1.06 B
- -$1.11 B
Y/Y
20.96%
10.17%
17.05%
50.61%
99.89%
4.42%
Profitability
Operating Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income Margin (%)
- 12.09%
- 10.90%
- 11.88%
- 25.35%
- 24.80%
- 28.12%
Y/Y
2.81%
9.84%
8.99%
20.51%
2.17%
13.39%
Net Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income Margin (%)
- 9.43%
- 7.66%
- 8.45%
- 21.25%
- 25.24%
- 27.81%
Y/Y
13.8%
18.77%
10.31%
28.81%
18.78%
10.18%
EBITDA
2021 | 4391000000.00 |
---|---|
2022 | 4410000000.00 |
2023 | 4402000000.00 |
2024 | 4819000000.00 |
2021 | 2131200000.00 |
---|---|
2022 | 1942900000.00 |
2023 | 2169000000.00 |
2024 | 2810900000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
EBITDA
- $4.41 B
- $4.40 B
- $4.82 B
- $1.94 B
- $2.17 B
- $2.81 B
Y/Y
0.43%
0.18%
9.47%
8.84%
11.64%
29.59%
Free Cash Flow (FCF)
2021 | 3416000000.00 |
---|---|
2022 | 1660000000.00 |
2023 | 2115000000.00 |
2024 | 3072000000.00 |
2021 | 1735900000.00 |
---|---|
2022 | 958400000.00 |
2023 | 749600000.00 |
2024 | 1303800000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Free Cash Flow (FCF)
- $1.66 B
- $2.12 B
- $3.07 B
- $958.40 M
- $749.60 M
- $1.30 B
Y/Y
51.41%
27.41%
45.25%
44.79%
21.79%
73.93%
Ratios
Return on Equity (ROE)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Equity (ROE)
- 7.04%
- 5.75%
- 6.59%
- 11.98%
- 13.51%
- 14.13%
Y/Y
20.36%
18.32%
14.61%
15.99%
12.77%
4.59%
Return on Assets (ROA)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Assets (ROA)
- 3.36%
- 2.81%
- 2.98%
- 10.19%
- 11.64%
- 12.33%
Y/Y
13.4%
16.37%
6.05%
19%
14.23%
5.93%
Debt to Equity
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Debt to Equity
- 63.54%
- 61.55%
- 80.80%
- 0.00%
- 0.00%
- 0.89%
Y/Y
14.57%
3.13%
31.28%
100%
0%
100%
Valuation
Enterprise Value
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value
- $78.57 B
- $88.48 B
- $89.06 B
- $92.80 B
- $115.73 B
- $183.52 B
Y/Y
7.19%
12.61%
0.67%
26.78%
24.7%
58.57%
Enterprise value to Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to Revenue
- 4.16
- 4.57
- 4.41
- 14.91
- 16.25
- 21.97
Y/Y
5.91%
9.69%
3.36%
32.8%
8.92%
35.26%
Enterprise value to EBITDA
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to EBITDA
- 17.82
- 20.10
- 18.48
- 47.77
- 53.36
- 65.29
Y/Y
7.59%
12.82%
8.05%
19.68%
11.71%
22.36%